Gland Pharma Q3: Strong and clean play on global generic injectables; accumulate Trading Calls - Equity F&O January 25, 2021Recommendations We believe dominance of profit/royalty-sharing aspect in the business model distinguishes Gland Pharma from other contract manufacturers Anubhav Sahu
